https://arstechnica.com/science/2020/05/the-antiviral-remdesivir-shortens-covid-19-recovery-times-study-shows/ https://arstechnica.com/science/2020/05/the-antiv

https://arstechnica.com/science/2020/05/the-antiviral-remdesivir-shortens-covid-19-recovery-times-study-shows/ https://arstechnica.com/science/2020/05/the-antiviral-remdes... participants who entered the trial more than 10 days after the onset of symptoms actually showed a better response to remdesivir than those who started being treated during the first 10 days of being symptomatic. It's not a huge improvement, but it doesn't seem to be too dependent on starting treatment early.